×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
KYMR – kymera therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
KYMR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/24
09:51 am
kymr
FDA Grants Fast Track Designation to Kymera Therapeutics, Inc. (KYMR)'s KT-621 for Eosinophilic Asthma [Yahoo! Finance]
Low
Report
FDA Grants Fast Track Designation to Kymera Therapeutics, Inc. (KYMR)'s KT-621 for Eosinophilic Asthma [Yahoo! Finance]
4/23
07:00 am
kymr
Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026
Low
Report
Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026
4/13
07:00 am
kymr
Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Moderate to Severe Asthma
Medium
Report
Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Moderate to Severe Asthma
4/9
07:00 am
kymr
Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate
Medium
Report
Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate
3/29
08:38 pm
kymr
Does Positive KT-621 Atopic Dermatitis Data Change The Bull Case For Kymera Therapeutics (KYMR)? [Yahoo! Finance]
Low
Report
Does Positive KT-621 Atopic Dermatitis Data Change The Bull Case For Kymera Therapeutics (KYMR)? [Yahoo! Finance]
3/28
11:12 am
kymr
Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting [Yahoo! Finance]
Low
Report
Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting [Yahoo! Finance]
3/28
11:00 am
kymr
Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting
Low
Report
Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting
3/16
10:58 am
kymr
Kymera Therapeutics (KYMR) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
Low
Report
Kymera Therapeutics (KYMR) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
8/11/2025
07:00 am
kymr
kymera therapeutics, inc.
MISS
Report
-7.2%
kymera therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/24
04:34 pm
kymr
Form 4 Kymera Therapeutics, For: Apr 22 Filed by: Booth Bruce
Low
Report
Form 4 Kymera Therapeutics, For: Apr 22 Filed by: Booth Bruce
4/24
04:30 pm
kymr
Form 4 Kymera Therapeutics, For: Apr 22 Filed by: Chadwick Jeremy G
Low
Report
Form 4 Kymera Therapeutics, For: Apr 22 Filed by: Chadwick Jeremy G
4/22
04:52 pm
kymr
Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Low
Report
Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
4/22
04:52 pm
kymr
Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Low
Report
Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
4/22
04:30 pm
kymr
Form 144 Kymera Therapeutics, Filed by: Chadwick Jeremy G
Low
Report
Form 144 Kymera Therapeutics, Filed by: Chadwick Jeremy G
4/16
06:30 pm
kymr
Form 4 Kymera Therapeutics, For: Apr 14 Filed by: Goodman Noah
Low
Report
Form 4 Kymera Therapeutics, For: Apr 14 Filed by: Goodman Noah
4/16
06:30 pm
kymr
Form 4 Kymera Therapeutics, For: Apr 14 Filed by: Chadwick Jeremy G
Low
Report
Form 4 Kymera Therapeutics, For: Apr 14 Filed by: Chadwick Jeremy G
4/16
06:17 pm
kymr
Form 4 Kymera Therapeutics, For: Apr 14 Filed by: Booth Bruce
Low
Report
Form 4 Kymera Therapeutics, For: Apr 14 Filed by: Booth Bruce
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: